跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达比加群酯胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dabigatran Etexilate Capsules
Approved
化学药品
Dabigatran Etexilate Capsules
HETERO LABS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Dec 1, 2024
Approval ID
8f25OehQOHR
Company
HETERO LABS LIMITED
Type
化学药品
Approval Details
Approval Id
8f25OehQOHR
Approval Number
国药准字HJ20240156
Generic Name
达比加群酯胶囊
Generic Name En
Dabigatran Etexilate Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
150mg(以达比加群酯计)
Reg Date
2024-12-01
Expired Date
2029-11-30
Company Name
HETERO LABS LIMITED
Company Address
Unit-III, 22-110, I.D.A, Jeedimetla(V), Quthbullapur(M), Medchal-Malkajgiri(Dist.), 500 055, Telangana State, India
Production Company Name
HETERO LABS LIMITED
Production Company Address
Unit-III, 22-110, I.D.A, Jeedimetla(V), Quthbullapur(M), Medchal-Malkajgiri(Dist.), 500 055, Telangana State, India
Company Detail Path
/organization/hetero-labs-limited
Production Company Detail Path
/organization/hetero-labs-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 1, 2024
Approval ID
8f25OehQOHR
Type
化学药品
Back to NMPA Approvals